Esperion wins FDA approval for new cholesterol-lowering drug Feb. 21, 2020 By Michael Fitzhugh No Comments Less than a month after landing a positive opinion from the EMA's CHMP, Esperion Therapeutics Inc. has won FDA approval for bempedoic acid as an adjunct to diet and maximally tolerated statin therapy. Read More